Study Finds ‘Significant Increase’ in Cancer Mortality After Mass Vaccination With 3rd COVID-19 Dose

Researchers observed “statistically significant increases” in mortality rates of all cancers, especially estrogen-related cancers, following mass vaccination with a third dose of mRNA COVID-19 vaccine, according to a recent paper.
Japan has the highest vaccination rates and is now conducting mass vaccinations with a seventh vaccine dose. According to the researchers, after mass vaccination began in 2021, there was a noticeable increase in cancer mortalities coinciding with the first and second COVID-19 vaccine doses.
Following vaccination with a third mRNA vaccine dose in 2022, researchers observed “significant excess mortalities” for all cancers and specifically estrogen and estrogen receptor alpha-sensitive cancers, including ovarian, leukemia, prostate, lip/oral/pharyngeal, pancreatic, and breast cancers. Notably, breast cancer had a “significant deficit mortality” in 2020 but shifted to excess mortality in 2022 following the rollout of the third vaccine dose.
Other than pancreatic cancer, which was steadily rising before the pandemic, the other five types of cancers were on a downward trend. Still, all six types of cancers exceeded predicted mortality values in 2021, 2022, or during both years.
In 2021, trends slowly shifted toward excess mortality, which continued to increase in 2022 for almost all age groups. The study found that in 2021, there was a significant excess mortality for all causes of 2.1 percent and 1.1 percent for all cancers. In 2022, excess all-cause mortality jumped to 9.6 percent and to 2.1 percent for all cancers.
According to the study, the number of deaths from all cancers was highest in the 80 to 84 age group, of which more than 90 percent had received a third vaccine dose. Nearly 100 percent of vaccines administered were mRNA vaccines, with Pfizer’s vaccine accounting for 78 percent and Moderna’s vaccine accounting for 22 percent.
The researchers said that although cancer mortality could be attributed to fewer cancer screenings and restricted access to health care during lockdowns, it doesn’t explain the significant increases in mortality observed for the six specific types of cancer in 2022, when restrictions on health care access to cancer screens or treatments seemed to have resolved.
“These particularly marked increases in mortality rates of these [ER alpha-sensitive] cancers may be attributable to several mechanisms of the mRNA-LNP vaccination rather than COVID-19 infection itself or reduced cancer care due to the lockdown,” they wrote.
Stephanie Seneff, a senior research scientist at the Massachusetts Institute of Technology, said the study provides compelling epidemiological evidence of a link between the rise in the prevalence of several cancers and the administration of multiple COVID-19 vaccines.
“It is reasonable to assume that additional thrombus-forming tendency noted with the mRNA-LNP vaccine could be extremely dangerous,” the authors wrote.
According to the study, viral and vaccine SARS-CoV-2 spike proteins have solid electropositive potential that could attach to electronegative glycoconjugates on the surfaces of red blood cells and other cells. The spike protein can also bind to the angiotensin-converting enzyme 2 (ACE2), which activates the immune system, causing vascular wall thickening, impaired mitochondrial function, and reactive oxygen species (ROS).
Researcher Hélène Banoun, with the French Institute of Health and Medical Research, told The Epoch Times that the findings of the paper published in Cureus, are consistent with her understanding of the carcinogenic danger of gene therapy products.
“Kevin McKernan says that he has found a correlation between the adverse effects caused by certain batches of vaccine and the amount of contaminating DNA, so it’s consistent. And you also have to take into account the immunotolerance induced by modified RNAs, which will facilitate cancer,” she said.